EP2364145A1 - Dosage forms for the rapid and sustained elevation of gastric ph - Google Patents
Dosage forms for the rapid and sustained elevation of gastric phInfo
- Publication number
- EP2364145A1 EP2364145A1 EP09755268A EP09755268A EP2364145A1 EP 2364145 A1 EP2364145 A1 EP 2364145A1 EP 09755268 A EP09755268 A EP 09755268A EP 09755268 A EP09755268 A EP 09755268A EP 2364145 A1 EP2364145 A1 EP 2364145A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- dosage form
- present
- pharmaceutical composition
- ppi
- blocker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12902908P | 2008-05-30 | 2008-05-30 | |
PCT/US2009/003281 WO2009145905A1 (en) | 2008-05-30 | 2009-05-29 | Dosage forms for the rapid and sustained elevation of gastric ph |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2364145A1 true EP2364145A1 (en) | 2011-09-14 |
EP2364145A4 EP2364145A4 (en) | 2013-11-13 |
Family
ID=41377439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09755268.1A Withdrawn EP2364145A4 (en) | 2008-05-30 | 2009-05-29 | Dosage forms for the rapid and sustained elevation of gastric ph |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2364145A4 (en) |
CA (1) | CA2740974A1 (en) |
WO (1) | WO2009145905A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US9265732B2 (en) | 2006-03-06 | 2016-02-23 | Pozen Inc. | Dosage forms for administering combinations of drugs |
EP2344139A1 (en) | 2008-09-09 | 2011-07-20 | AstraZeneca AB | Method for delivering a pharmaceutical composition to patient in need thereof |
EA201290026A1 (en) | 2009-06-25 | 2012-07-30 | Астразенека Аб | A METHOD FOR TREATING A PATIENT THAT HAS A RISK OF DEVELOPMENT OF ANALISM ASSOCIATED WITH THE RECEPTION OF NONSTEROID ANTI-INFLAMMATORY MEDIA |
BR112014016085A8 (en) | 2011-12-28 | 2017-07-04 | Pozen Inc | Enhanced compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1559612A (en) * | 2004-02-18 | 2005-01-05 | 孔庆忠 | Medicinal mixture for treating digestire system anabrosis |
US20070031497A1 (en) * | 2002-10-16 | 2007-02-08 | Orexo Ab | Gastric acid secretion inhibiting composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0101379D0 (en) * | 2001-04-18 | 2001-04-18 | Diabact Ab | Composition that inhibits gastric acid secretion |
US20070243251A1 (en) * | 2002-12-20 | 2007-10-18 | Rajneesh Taneja | Dosage Forms Containing A PPI, NSAID, and Buffer |
US20060165797A1 (en) * | 2005-01-12 | 2006-07-27 | Pozen Inc. | Dosage form for treating gastrointestinal disorders |
WO2008057802A2 (en) * | 2006-10-27 | 2008-05-15 | The Curators Of The University Of Missouri | Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same |
-
2009
- 2009-05-29 WO PCT/US2009/003281 patent/WO2009145905A1/en active Application Filing
- 2009-05-29 EP EP09755268.1A patent/EP2364145A4/en not_active Withdrawn
- 2009-05-29 CA CA2740974A patent/CA2740974A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070031497A1 (en) * | 2002-10-16 | 2007-02-08 | Orexo Ab | Gastric acid secretion inhibiting composition |
CN1559612A (en) * | 2004-02-18 | 2005-01-05 | 孔庆忠 | Medicinal mixture for treating digestire system anabrosis |
Non-Patent Citations (1)
Title |
---|
See also references of WO2009145905A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2364145A4 (en) | 2013-11-13 |
CA2740974A1 (en) | 2009-12-03 |
WO2009145905A1 (en) | 2009-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060165797A1 (en) | Dosage form for treating gastrointestinal disorders | |
US9636306B2 (en) | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient | |
EP1411900B1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs | |
US6605303B1 (en) | Oral pharmaceutical extended release dosage form | |
JP2012153712A (en) | Heartburn treatment | |
WO2009145905A1 (en) | Dosage forms for the rapid and sustained elevation of gastric ph | |
EP3377046A1 (en) | Pharmaceutical composition containing a non-steroidal antiinflammatory drug and a proton pump inhibitor | |
WO2013122554A1 (en) | Pellet formulations comprising esomeprazole | |
JP2007504261A (en) | Proton Pump Inhibitor Formulation, and Method-Related Application for Manufacturing and Using the Formulation | |
EP2015731B1 (en) | Pharmaceutical compositions comprising non-steroidal antiinflammatory drug, acetaminophen and proton pump inhibitor | |
EP1841409A2 (en) | Dosage form for treating gastrointestinal disorders | |
WO2009137648A1 (en) | Multilayer proton pump inhibitor tablets | |
WO2012162777A9 (en) | Oral pharmaceutical composition comprising a proton pump inhibitor and a prokinetic agent that can be used in excess stomach acid disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20110405 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1155655 Country of ref document: HK |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 9/20 20060101AFI20131003BHEP Ipc: A61K 31/4439 20060101ALI20131003BHEP Ipc: A61K 45/06 20060101ALI20131003BHEP Ipc: A61K 9/24 20060101ALI20131003BHEP Ipc: A61K 9/46 20060101ALI20131003BHEP Ipc: A61K 31/4164 20060101ALI20131003BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20131011 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20140509 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1155655 Country of ref document: HK |